AMENDMENT NO. 3 TO SHARE PURCHASE AGREEMENT
Exhibit 3
EXECUTION VERSION
AMENDMENT NO. 3 TO SHARE PURCHASE AGREEMENT
THIS AMENDMENT NO. 3 TO SHARE PURCHASE AGREEMENT (this “Amendment”), dated as of October 26, 2020, is entered into by and between PW Medtech Group Limited, a Cayman Islands company (the “Seller”) and Point Forward Holdings Limited, a Cayman Islands company (the “Purchaser”).
WHEREAS, the Seller and Beachhead Holdings Limited, a Cayman Islands company (“Beachhead”) entered into a share purchase agreement dated as of September 18, 2019 (as amended by amendment no. 1 thereto dated as of March 17, 2020 and amendment no. 2 thereto dated as of May 5, 2020, the “SPA”), pursuant to and subject to the terms and conditions of which, the Seller has agreed to sell to Beachhead, and Beachhead has agreed to purchase from the Seller the Sale Shares;
WHEREAS, pursuant to an assignment agreement dated as of May 5, 2020 (the “Assignment Agreement”) by and among the Seller, Beachhead and the Purchaser, Beachhead has absolutely and irrevocably assigned to the Purchaser, and the Purchaser has accepted the assignment from Beachhead, all the interests, rights, obligations and covenants of Beachhead with respect to and in connection with the sale and purchase of 385,000 Ordinary Shares (collectively, the “Assigned Shares”) under the SPA;
WHEREAS, on May 8, 2020, the Seller completed the sale of Assigned Shares to the Purchaser pursuant to the terms and conditions of the SPA and the Assignment Agreement;
WHEREAS, Section 6.4 of the SPA provides that the SPA may be amended by written instrument making specific reference to the SPA signed by the party of the SPA against whom enforcement of such amendment is sought; and
WHEREAS, the parties hereto desire to amend the SPA pursuant to the terms as set forth herein.
NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
1
[SIGNATURE PAGES FOLLOW]
2
PW
Medtech Group Limited ![]() | ||
By: | /s/ Yue'e Zhang | |
Name: Yue'e Zhang | ||
Title: Executive Director and Chief Executive Officer |
[Signature Page to Amendment No. 3 to Share Purchase Agreement]
Point Forward Holdings Limited | ||
By: | /s/ Xxx Xx | |
Name: Xxx Xx | ||
Title: Director |
[Signature Page to Amendment No. 3 to Share Purchase Agreement]
Schedule A
Form of Payment Notice
EXECUTION VERSION
AMENDMENT NO. 3 TO SHARE PURCHASE AGREEMENT
THIS AMENDMENT NO. 3 TO SHARE PURCHASE AGREEMENT (this “Amendment”), dated as of October 26, 2020, is entered into by and between PW Medtech Group Limited, a Cayman Islands company (the “Seller”) and Double Double Holdings Limited, a Cayman Islands company (the “Purchaser”).
WHEREAS, the Seller and Beachhead Holdings Limited, a Cayman Islands company (“Beachhead”) entered into a share purchase agreement dated as of September 18, 2019 (as amended by amendment no. 1 thereto dated as of March 17, 2020 and amendment no. 2 thereto dated as of May 5, 2020, the “SPA”), pursuant to and subject to the terms and conditions of which, the Seller has agreed to sell to Beachhead, and Beachhead has agreed to purchase from the Seller the Sale Shares;
WHEREAS, pursuant to an assignment agreement dated as of May 5, 2020 (the “Assignment Agreement”) by and among the Seller, Beachhead and the Purchaser, Beachhead has absolutely and irrevocably assigned to the Purchaser, and the Purchaser has accepted the assignment from Beachhead, all the interests, rights, obligations and covenants of Beachhead with respect to and in connection with the sale and purchase of 615,000 Ordinary Shares (collectively, the “Assigned Shares”) under the SPA;
WHEREAS, on May 8, 2020, the Seller completed the sale of Assigned Shares to the Purchaser pursuant to the terms and conditions of the SPA and the Assignment Agreement;
WHEREAS, Section 6.4 of the SPA provides that the SPA may be amended by written instrument making specific reference to the SPA signed by the party of the SPA against whom enforcement of such amendment is sought; and
WHEREAS, the parties hereto desire to amend the SPA pursuant to the terms as set forth herein.
NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
2. Payment of Price Adjustment Amount. Notwithstanding anything to the contrary in the SPA, the Purchaser hereby agrees to, as soon as practicable and in any event within five (5) Business Days after the date of this Amendment, pay to the Seller immediately available funds in US dollars by wire transfer in an amount equal to the product of (a) US$19.00 multiplied by (b) the number of all Assigned Shares into an account designated by the Seller in a written notice to the Purchaser on or about the date of this Amendment in substantially the form attached hereto as Schedule A.
1
[SIGNATURE PAGES FOLLOW]
2
PW
Medtech Group Limited ![]() | ||
By: | /s/ Yue'e Zhang | |
Name: Yue'e Zhang | ||
Title: Executive Director and Chief Executive Officer |
[Signature Page to Amendment No. 3 to Share Purchase Agreement]
Double Double Holdings Limited | ||
By: | /s/ Xxx Xx | |
Name: Xxx Xx | ||
Title: Director |
[Signature Page to Amendment No. 3 to Share Purchase Agreement]
Schedule A
Form of Payment Notice